These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15482266)

  • 1. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis.
    Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C
    Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraarticular trabecular bone loss at the ultradistal radius and increased arterial stiffening in postmenopausal patients with rheumatoid arthritis.
    Tanaka K; Inaba M; Goto H; Nagata-Sakurai M; Sakai S; Yamada S; Ueda M; Ishimura E; Nishizawa Y
    J Rheumatol; 2006 Apr; 33(4):652-8. PubMed ID: 16583470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis.
    Torikai E; Kageyama Y; Takahashi M; Suzuki M; Ichikawa T; Nagafusa T; Nagano A
    Rheumatology (Oxford); 2006 Jun; 45(6):761-4. PubMed ID: 16436492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.
    St Clair EW; Moak SA; Wilkinson WE; Sanders L; Lang T; Greenwald RA
    J Rheumatol; 1998 Aug; 25(8):1472-9. PubMed ID: 9712086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
    El Miedany YM; Abubakr IH; El Baddini M
    J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
    Kaji T; Yasui T; Suto M; Mitani R; Morine M; Uemura H; Maeda K; Irahara M
    Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a psoriatic osteopathy? -- the activity of bone resorption in psoriatics is related to inflammatory joint process.
    Hein G; Schmidt F; Barta U; Müller A
    Eur J Med Res; 1999 May; 4(5):187-92. PubMed ID: 10336408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in bone turnover markers during 14-day 6 degrees head-down bed rest.
    Kim H; Iwasaki K; Miyake T; Shiozawa T; Nozaki S; Yajima K
    J Bone Miner Metab; 2003; 21(5):311-5. PubMed ID: 12928833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased cellular activity and replicative capacity of osteoblastic cells isolated from the periarticular bone of rheumatoid arthritis patients compared with osteoarthritis patients.
    Yudoh K; Matsuno H; Osada R; Nakazawa F; Katayama R; Kimura T
    Arthritis Rheum; 2000 Oct; 43(10):2178-88. PubMed ID: 11037877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data.
    Slatkowsky-Christensen B; Mowinckel P; Loge JH; Kvien TK
    Arthritis Rheum; 2007 Dec; 57(8):1404-9. PubMed ID: 18050180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis.
    Furumitsu Y; Inaba M; Yukioka K; Yukioka M; Kumeda Y; Azuma Y; Ohta T; Ochi T; Nishizawa Y; Morii H
    J Rheumatol; 2000 Jan; 27(1):64-70. PubMed ID: 10648019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups.
    Lisignoli G; Manferdini C; Codeluppi K; Piacentini A; Grassi F; Cattini L; Filardo G; Facchini A
    J Cell Physiol; 2009 Oct; 221(1):154-60. PubMed ID: 19492413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.